2aov: Difference between revisions

New page: left|200px<br /> <applet load="2aov" size="450" color="white" frame="true" align="right" spinBox="true" caption="2aov, resolution 2.48Å" /> '''Histamine Methyltra...
 
No edit summary
Line 1: Line 1:
[[Image:2aov.gif|left|200px]]<br />
[[Image:2aov.gif|left|200px]]<br /><applet load="2aov" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2aov" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2aov, resolution 2.48&Aring;" />
caption="2aov, resolution 2.48&Aring;" />
'''Histamine Methyltransferase Complexed with the Antifolate Drug Metoprine'''<br />
'''Histamine Methyltransferase Complexed with the Antifolate Drug Metoprine'''<br />


==Overview==
==Overview==
In mammals, histamine action is terminated through metabolic inactivation, by histamine N-methyltransferase (HNMT) and diamine oxidase. In addition, to three well-studied pharmacological functions, smooth muscle, contraction, increased vascular permeability, and stimulation of gastric, acid secretion, histamine plays important roles in neurotransmission, immunomodulation, and regulation of cell proliferation. The histamine, receptor H1 antagonist diphenhydramine, the antimalarial drug amodiaquine, the antifolate drug metoprine, and the anticholinesterase drug tacrine (an, early drug for Alzheimer's disease) are surprisingly all potent HNMT, inhibitors, having inhibition constants in the range of 10-100nM. We have, determined the structural mode of interaction of these four inhibitors, with HNMT. Despite their structural diversity, they all occupy the, histamine-binding site, thus blocking access to the enzyme's active site., Near the N terminus of HNMT, several aromatic residues (Phe9, Tyr15, and, Phe19) adopt different rotamer conformations or become disordered in the, enzyme-inhibitor complexes, accommodating the diverse, rigid hydrophobic, groups of the inhibitors. The maximized shape complementarity between the, protein aromatic side-chains and aromatic ring(s) of the inhibitors are, responsible for the tight binding of these varied inhibitors.
In mammals, histamine action is terminated through metabolic inactivation by histamine N-methyltransferase (HNMT) and diamine oxidase. In addition to three well-studied pharmacological functions, smooth muscle contraction, increased vascular permeability, and stimulation of gastric acid secretion, histamine plays important roles in neurotransmission, immunomodulation, and regulation of cell proliferation. The histamine receptor H1 antagonist diphenhydramine, the antimalarial drug amodiaquine, the antifolate drug metoprine, and the anticholinesterase drug tacrine (an early drug for Alzheimer's disease) are surprisingly all potent HNMT inhibitors, having inhibition constants in the range of 10-100nM. We have determined the structural mode of interaction of these four inhibitors with HNMT. Despite their structural diversity, they all occupy the histamine-binding site, thus blocking access to the enzyme's active site. Near the N terminus of HNMT, several aromatic residues (Phe9, Tyr15, and Phe19) adopt different rotamer conformations or become disordered in the enzyme-inhibitor complexes, accommodating the diverse, rigid hydrophobic groups of the inhibitors. The maximized shape complementarity between the protein aromatic side-chains and aromatic ring(s) of the inhibitors are responsible for the tight binding of these varied inhibitors.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2AOV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 4DI and C2M as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Histamine_N-methyltransferase Histamine N-methyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.1.8 2.1.1.8] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2AOV OCA].  
2AOV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=4DI:'>4DI</scene> and <scene name='pdbligand=C2M:'>C2M</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Histamine_N-methyltransferase Histamine N-methyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.1.8 2.1.1.8] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2AOV OCA].  


==Reference==
==Reference==
Line 19: Line 18:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Cheng, X.]]
[[Category: Cheng, X.]]
[[Category: Horton, J.R.]]
[[Category: Horton, J R.]]
[[Category: Nishibori, M.]]
[[Category: Nishibori, M.]]
[[Category: Sawada, K.]]
[[Category: Sawada, K.]]
Line 27: Line 26:
[[Category: protein-drug complex]]
[[Category: protein-drug complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:53:25 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:29:27 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA